232 447

Cited 12 times in

Intraoperative Transfusion is Independently Associated with a Worse Prognosis in Resected Pancreatic Cancer-a Retrospective Cohort Analysis

DC Field Value Language
dc.contributor.author강창무-
dc.contributor.author노승윤-
dc.contributor.author이우정-
dc.contributor.author최문석-
dc.contributor.author황호경-
dc.date.accessioned2020-04-13T16:55:22Z-
dc.date.available2020-04-13T16:55:22Z-
dc.date.issued2020-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/175565-
dc.description.abstractBACKGROUNDS: Investigate whether intraoperative transfusion is a negative prognostic factor for oncologic outcomes of resected pancreatic cancer. METHODS: From June 2004 to January 2014, the medical records of 305 patients were retrospectively reviewed, who underwent pancreatoduodenectomy, pylorus preserving pancreatoduodenectomy, total pancreatectomy, distal pancreatectomy for pancreatic cancer. Patients diagnosed with metastatic disease (n = 3) and locally advanced diseases (n = 15) were excluded during the analysis, and total of 287 patients were analyzed. RESULTS: The recurrence and disease-specific survival rates of the patients who received intraoperative transfusion showed poorer survival outcomes compared to those who did not (P = 0.031, P = 0.010). Through multivariate analysis, T status (HR (hazard ratio) = 2.04, [95% CI (confidence interval): 1.13-3.68], P = 0.018), N status (HR = 1.46 [95% CI: 1.00-2.12], P = 0.045), adjuvant chemotherapy (HR = 0.51, [95% CI: 0.35-0.75], P = 0.001), intraoperative transfusion (HR = 1.94 [95% CI: 1.23-3.07], P = 0.004) were independent prognostic factors of disease-specific survival after surgery. As well, adjuvant chemotherapy (HR = 0.67, [95% CI: 0.46-0.97], P = 0.035) was independently associated with tumor recurrence. Estimated blood loss was one of the most powerful factors associated with intraoperative transfusion (P < 0.001). CONCLUSIONS: Intraoperative transfusion can be considered as an independent prognostic factor of resected pancreatic cancer. As well, it can be avoided by following strict transfusion policy and using advanced surgical techniques to minimize bleeding during surgery.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherMDPI AG-
dc.relation.isPartOfJOURNAL OF CLINICAL MEDICINE-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleIntraoperative Transfusion is Independently Associated with a Worse Prognosis in Resected Pancreatic Cancer-a Retrospective Cohort Analysis-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학교실)-
dc.contributor.googleauthorSi Youn Kim-
dc.contributor.googleauthorMunseok Choi-
dc.contributor.googleauthorHo Kyoung Hwang-
dc.contributor.googleauthorSeoung Yoon Rho-
dc.contributor.googleauthorWoo Jung Lee-
dc.contributor.googleauthorChang Moo Kang-
dc.identifier.doi10.3390/jcm9030689-
dc.contributor.localIdA00088-
dc.contributor.localIdA05469-
dc.contributor.localIdA02993-
dc.contributor.localIdA05885-
dc.contributor.localIdA04497-
dc.relation.journalcodeJ03556-
dc.identifier.eissn2077-0383-
dc.identifier.pmid32143434-
dc.subject.keywordblood loss-
dc.subject.keywordintraoperative-
dc.subject.keywordpancreatic cancer-
dc.subject.keywordsurvival rates-
dc.subject.keywordtransfusion-
dc.contributor.alternativeNameKang, Chang Moo-
dc.contributor.affiliatedAuthor강창무-
dc.contributor.affiliatedAuthor노승윤-
dc.contributor.affiliatedAuthor이우정-
dc.contributor.affiliatedAuthor최문석-
dc.contributor.affiliatedAuthor황호경-
dc.citation.volume9-
dc.citation.number3-
dc.citation.startPageE689-
dc.identifier.bibliographicCitationJOURNAL OF CLINICAL MEDICINE, Vol.9(3) : E689, 2020-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.